We are live on ! Find out more
CGA

Crescent Grove Advisors Portfolio holdings

AUM $1.04B
1-Year Est. Return 17.78%
This Fund
S&P 500
This Quarter Est. Return
+6.66%
1 Year Est. Return
+17.78%
3 Year Est. Return
+51.16%
5 Year Est. Return
+28.04%
10 Year Est. Return
AUM
$390M
AUM Growth
+$43.1M
Cap. Flow
+$21.8M
Cap. Flow %
5.59%
Top 10 Hldgs %
63.13%
Holding
156
New
11
Increased
42
Reduced
23
Closed
15

Sector Composition

Rank Sector Weight
1 Technology 40.79%
2 Consumer Discretionary 8.39%
3 Industrials 6.43%
4 Financials 4.81%
5 Materials 1.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GD icon
126
General Dynamics
GD
$105B
$206K 0.05%
+1,000
New +$200K
CTG
127
DELISTED
Computer Task Group, Inc.
CTG
$205K 0.05%
38,324
+4,002
+12% +$21.5K
EXAS
128
DELISTED
Exact Sciences
EXAS
$200K 0.05%
+4,250
New +$171K
PETX
129
DELISTED
Aratana Therapeutics, Inc.
PETX
$198K 0.05%
32,250
FLO icon
130
Flowers Foods
FLO
$1.64B
$188K 0.05%
10,000
FDUS icon
131
Fidus Investment
FDUS
$737M
$181K 0.05%
11,277
ESNC
132
DELISTED
EnSync Inc
ESNC
$152K 0.04%
294,456
+30,221
+11% +$12.4K
DYSL
133
DELISTED
Dynasil Corporation of America
DYSL
$142K 0.04%
113,465
BKMU
134
DELISTED
Bank Mutual Corp
BKMU
$125K 0.03%
12,341
HNRG icon
135
Hallador Energy
HNRG
$718M
$120K 0.03%
21,000
STON
136
DELISTED
StoneMor Inc.
STON
$96K 0.02%
14,658
SSI
137
DELISTED
Stage Stores Inc
SSI
$93K 0.02%
50,347
CRDF icon
138
Cardiff Oncology
CRDF
$64.3M
$51K 0.01%
972
+444
+84% +$27.7K
PDS
139
Precision Drilling
PDS
$1.09B
$47K 0.01%
750
SLS icon
140
SELLAS Life Sciences
SLS
$2.23B
$42K 0.01%
80
+13
+19% +$8.58K
HURA
141
TuHURA Biosciences
HURA
$134M
$23K 0.01%
+2
New +$54.8K
BBWI icon
142
Bath & Body Works
BBWI
$4.01B
-4,948
Closed -$216K
DD icon
143
DuPont de Nemours
DD
$18.6B
-1,816
Closed -$292K
DRI icon
144
Darden Restaurants
DRI
$22.5B
-3,000
Closed -$271K
HDV
145
iShares Core High Dividend ETF
HDV
$14.4B
-13,660
Closed -$227K
NVS icon
146
Novartis
NVS
$295B
-3,131
Closed -$234K
PRTA icon
147
Prothena Corp
PRTA
$458M
-5,000
Closed -$271K
XLY icon
148
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
$21.4B
-34,720
Closed -$1.56M
CSII
149
DELISTED
Cardiovascular Systems, Inc.
CSII
-10,100
Closed -$326K
ELVT
150
DELISTED
Elevate Credit, Inc.
ELVT
-10,000
Closed -$79K

Similar funds

Crescent Grove Advisors's Q3 2017 Portfolio in Review

As of Q3 2017, Crescent Grove Advisors held 156 positions worth $390M, up 12% from $347M the previous quarter. Its ten largest holdings account for 63% of the portfolio.

Crescent Grove Advisors deployed $21.8M of net new capital in Q3 2017, opening 11 new positions and adding to 42 existing holdings. Its largest new stake was iShares Core MSCI EAFE ETF: 39,113 shares worth $2.51M.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 37% a quarter earlier, followed by Consumer Discretionary and Industrials.

On the sell side, the largest reduction was ManpowerGroup, an estimated $4.37M trimmed.

  • Crescent Grove Advisors's largest Q3 2017 buy was iShares Core MSCI EAFE ETF: 39,113 shares worth $2.51M.
  • Crescent Grove Advisors added most to Fidelity National Information Services in Q3 2017, an estimated $18.7M increase.
  • Crescent Grove Advisors's biggest Q3 2017 reduction was ManpowerGroup, cutting an estimated $4.37M.
  • Crescent Grove Advisors fully exited Onebeacon Insurance Group Ltd in Q3 2017, selling an estimated $2.29M.
  • Crescent Grove Advisors's ten largest holdings make up 63% of its $390M portfolio in Q3 2017.
  • Crescent Grove Advisors opened 11 new positions and closed 15 in Q3 2017.
  • Crescent Grove Advisors's portfolio value rose 12% quarter-over-quarter to $390M.

Based on Crescent Grove Advisors's 13F filing for Q3 2017, filed 6 Nov 2017.